136 related articles for article (PubMed ID: 34540189)
1. Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE.
Yang W; Li X; Zhao L; Zhao F
J Healthc Eng; 2021; 2021():8556965. PubMed ID: 34540189
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.
Wang Q; Wang LX; Zhang CY; Bai N; Feng C; Zhang ZM; Wang L; Gao ZZ
Mol Cell Biochem; 2022 May; 477(5):1477-1488. PubMed ID: 35166986
[TBL] [Abstract][Full Text] [Related]
3. CRNDE inducing cisplatin resistance through SRSF1/TIA1 signaling pathway in ovarian cancer.
Wu J; Ni X; Yu Z; Wu S; Liu Z
Pathol Res Pract; 2022 Jul; 235():153957. PubMed ID: 35653925
[TBL] [Abstract][Full Text] [Related]
4. A Multi-Faceted Analysis Showing
Balcerak A; Szafron LA; Rubel T; Swiderska B; Bonna AM; Konarzewska M; Sołtyszewski I; Kupryjanczyk J; Szafron LM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673965
[No Abstract] [Full Text] [Related]
5. Retracted: Reversal of Radiotherapy Resistance of Ovarian Cancer Cell Strain CAOV3/R by Targeting lncRNA CRNDE.
Healthcare Engineering JO
J Healthc Eng; 2022; 2022():9763145. PubMed ID: 36465240
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis.
Chen KY; Zhu SG; He JW; Duan XP
Neoplasma; 2022 Jul; 69(4):918-930. PubMed ID: 35652619
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CRNDE regulates the growth and migration of prostate cancer cells by targeting microRNA-146a-5p.
Fu D; Zang L; Li Z; Fan C; Jiang H; Men T
Bioengineered; 2021 Dec; 12(1):2469-2479. PubMed ID: 34232111
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA CRNDE competed endogenously with miR-205 to promote proliferation and metastasis of melanoma cells by targeting CCL18.
Xu L; Zhang Y; Zhao Z; Chen Z; Wang Z; Xu S; Zhang X; Liu T; Yu S
Cell Cycle; 2018; 17(18):2296-2308. PubMed ID: 30257602
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression.
Zhang M; Gao C; Yang Y; Li G; Dong J; Ai Y; Chen N; Li W
Oncol Res; 2018 Sep; 26(8):1245-1255. PubMed ID: 28550688
[TBL] [Abstract][Full Text] [Related]
11. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
Xu QF; Tang YX; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms.
Ghafouri-Fard S; Safarzadeh A; Hussen BM; Taheri M; Mokhtari M
Pathol Res Pract; 2023 Apr; 244():154387. PubMed ID: 36893710
[TBL] [Abstract][Full Text] [Related]
13. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.
Zhang J; Zhang R; Ye Y
Bioengineered; 2021 Dec; 12(2):10541-10552. PubMed ID: 34709112
[TBL] [Abstract][Full Text] [Related]
15. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA CRNDE Promotes Proliferation of Gastric Cancer Cells by Targeting miR-145.
Hu CE; Du PZ; Zhang HD; Huang GJ
Cell Physiol Biochem; 2017; 42(1):13-21. PubMed ID: 28490034
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CRNDE enhances cervical cancer progression by suppressing PUMA expression.
Zhang JJ; Fan LP
Biomed Pharmacother; 2019 Sep; 117():108726. PubMed ID: 31202167
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
Sun XH; Fan WJ; An ZJ; Sun Y
Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
